Novel KIF26A variants associated with pediatric intestinal pseudo-obstruction (PIPO) and brain developmental defects.

KIF26A brain malformations congenital megacolon exome sequencing kinesin neurodevelopmental disorder

Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
21 Sep 2024
Historique:
revised: 01 09 2024
received: 01 07 2024
accepted: 07 09 2024
medline: 21 9 2024
pubmed: 21 9 2024
entrez: 21 9 2024
Statut: aheadofprint

Résumé

Pediatric intestinal pseudo-obstruction (PIPO) is a rare congenital disorder of the enteric nervous system with distal colon aganglionosis potentially leading to intestinal obstruction. Recently, biallelic variants in KIF26A, encoding a crucial motor protein for the migration and differentiation of enteric neural crest cells, have been associated with a neurodevelopmental condition featuring cortical defects and PIPO-like features, though in absence of aganglionosis. So far, only 10 patients have been reported. In this study, we investigated three subjects with congenital hydrocephalus, neurodevelopmental impairment, and intestinal obstruction megacolon syndrome. Brain MRI revealed malformations within cortical dysplasia spectrum, including polymicrogyria and heterotopia. Pathology study of the intestine revealed aganglionosis and elevated acetylcholinesterase activity in parasympathetic nerve fibers. Through trio-exome sequencing (ES), we detected four novel biallelic KIF26A variants, including two missense changes (#1) and two distinct homozygous truncating variants in (#2 and #3). All variants are rare and predicted to be deleterious according to in silico tools. To characterize the impact of the missense variants, we performed 3D protein modeling using Alphafold3 and YASARA. Mutants exhibited increased energy scores compared to wild-type protein, supporting a significant structural destabilization of the protein. Our study expands the genotype and phenotype spectrum of the emerging KIF26A-related disorder.

Identifiants

pubmed: 39305096
doi: 10.1111/cge.14621
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). Clinical Genetics published by John Wiley & Sons Ltd.

Références

Thapar N, Saliakellis E, Benninga MA, et al. Paediatric intestinal pseudo‐obstruction: ESPGHAN recommendations. J Pediatr Gastroenterol Nutr. 2018;66(6):991‐1019.
Karim A, Tang CS, Tam PK. Genetic landscape of Hirschsprung disease. Front Pediatr. 2021;9:638093.
Nishikawa M, Scala M, Umair M, et al. p.F28S RAC3 variant disrupts cortical development. J Med Genet. 2023;60(3):223‐232.
Zhou R, Niwa S, Homma N, et al. KIF26A is an unconventional kinesin and regulates GDNF‐Ret signaling in enteric neuronal development. Cell. 2009;139(4):802‐813.
Almannai M, AlAbdi L, Maddirevula S, et al. KIF26A mutations in congenital hydrocephalus with megacolon. Hum Genet. 2023;142(3):399‐405.
Qian X, DeGennaro EM, Talukdar M, et al. Loss of KIF26A causes brain malformations. Dev Cell. 2022;57(20):2381‐2396.e13.
Scala M, Accogli A, De Grandis E, et al. MYH3 mutation in Sheldon‐Hall syndrome. Am J Med Genet A. 2018;176(3):663‐667.
Scala M, Nishikawa M, Ito H, et al. RAC3 variant‐specific changes disrupt corticogenesis. Brain. 2022;145(9):3308‐3327.
Julies MG, Moore SW, Kotze MJ, du Plessis L. RET mutations in Hirschsprung's disease in South Africa. Eur J Hum Genet. 2001;9(6):419‐423.
Eketjäll S, Ibáñez CF. GDNF mutations in Hirschsprung disease. Hum Mol Genet. 2002;11(3):325‐329.
Elmaleh‐Berges M, Baumann C, Noel‐Petroff N, et al. Temporal bone abnormalities in Waardenburg syndrome with SOX10 mutations. Am J Neuroradiol. 2013;34:1257‐1263.
Weese‐Mayer DE, Shannon DC, Keens TG, Silvestri JM. Congenital central hypoventilation syndrome: diagnosis and management. Am J Respir Crit Care Med. 1999;160:368‐373.
Besset V, Scott RP, Ibáñez CF. c‐ret receptor activation and signaling. J Biol Chem. 2000;275(50):39159‐39166.
Tanaka H, Moroi K, Iwai J, et al. Endothelin B receptor mutations in Hirschsprung's disease. J Biol Chem. 1998;273:11378‐11383.
Wang L, Tanaka Y, Wang D, et al. KIF26A and focal adhesion kinase in nociceptive responses. Cell Rep. 2018;24(11):2894‐2907.
Miki H, Okada Y, Hirokawa N. Kinesin superfamily: structure and function. Trends Cell Biol. 2005;15(9):467‐476.
Calalb MB, Polte TR, Hanks SK. Focal adhesion kinase phosphorylation and Src kinases. Mol Cell Biol. 1995;15(2):954‐963.
McNeely KC, Cupp TD, Little JN, et al. Kinesin‐6 Kif20b mutations and cortical neuron defects. Neural Dev. 2017;12(1):5.
Scala M, Nishikawa M, Nagata KI, Striano P. Neurodevelopmental Disorders and Rac GTPases. Cells. 2021;10(12):3395.
Rivera Alvarez J, Asselin L, Tilly P, et al. Kinesin Kif21b and cortical neuron migration. Cell Rep. 2023;42(7):112744.

Auteurs

Mohammad Sadegh Shams Nosrati (MSS)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Alireza Doustmohammadi (A)

Department of Bioinformatics and Computational Biophysics, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.

Mariasavina Severino (M)

Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Ferruccio Romano (F)

Genomics and Clinical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Mahdi Zafari (M)

Department of Bioengineering, Northeastern University, Boston, Massachusetts, USA.

Amir Hesam Nemati (AH)

Department of Epidemiology and Biostatistics, Pasteur Institute of Iran, Tehran, Iran.

Clara Velmans (C)

Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christian Netzer (C)

Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Jonas Breuer (J)

Department of Paediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Ilse Julia Broekaert (IJ)

Department of Paediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Alexander Joachim (A)

Department of Pediatrics, Faculty of Health, Helios University Medical Center Wuppertal, Witten/Herdecke University, Witten, Germany.

Nihad Almasri (N)

Department of Rehabilitation Sciences College of Health Sciences, Qatar University, Doha, Qatar.
Department of Physiotherapy School of Rehabilitation Sciences, University of Jordan, Amman, Jordan.

Michael C Kruer (MC)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.

Peter Skidmore (P)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
College of Health Solutions, Arizona State University, Tempe, Arizona, USA.

Pritha Bisarad (P)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.

Jumana Hoque (J)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.

Somayeh Bakhtiari (S)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.

Annalaura Torella (A)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.

Vincenzo Nigro (V)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.

Francesca Buffelli (F)

Fetal-Perinatal Pathology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy.

Ezio Fulcheri (E)

Fetal-Perinatal Pathology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy.

Annette Müller (A)

Pediatric Pathology, University Clinic of Cologne, Cologne, Germany.

Federico Zara (F)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Valeria Capra (V)

Genomics and Clinical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Marcello Scala (M)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Classifications MeSH